Furthermore, we demonstrate that specific inhibition of HSF1 overcomes resistance to GPX4 inhibition and significantly increases the sensitivity of resistant cancer cells in vitro and tumors in vivo to ferroptosis. The gene discussed is HSF1; the disease is cancer.